MedPath
HSA Approval

AMINOPHYLLINE INJECTION 0.25 g/10 ml

SIN03471P

AMINOPHYLLINE INJECTION 0.25 g/10 ml

AMINOPHYLLINE INJECTION 0.25 g/10 ml

June 21, 1989

ATLANTIC PHARMACEUTICAL (S) PTE LTD

ATLANTIC PHARMACEUTICAL (S) PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantATLANTIC PHARMACEUTICAL (S) PTE LTD
Licence HolderATLANTIC PHARMACEUTICAL (S) PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION

INTRAVENOUS

Medical Information

R03DA05

aminophylline

Manufacturer Information

atlantic pharmaceutical (s) pte ltd

ATLANTIC LABORATORIES CORPN LTD

Active Ingredients

AMINOPHYLLINE (DIHYRATE) eq THEOPHYLLINE 19.7MG

0.25 g/10 ml

Aminophylline

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

AMINOPHYLLINE INJECTION 0.25 g/10 ml - HSA Approval | MedPath